1. United States Renal Data System (USRDS). Incidence, prevalence, patient characteristics, and treatment modalities. In: 2017 USRDS annual data report: epidemiology of kidney disease in the United States. Bethesda: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2015. https://www.usrds.org/annual-data-report/current-adr/. Accessed 30 Sep 2020.
2. United States Renal Data System (USRDS). Medicare expenditures for persons with ESRD. In: 2015 USRDS annual data report: epidemiology of kidney disease in the United States. Bethesda: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2015. https://www.usrds.org/annual-data-report/current-adr/. Accessed 30 Sep 2020.
3. National Kidney Foundation-Dialysis Outcomes Quality Initiative (NKF-KDOQI). Clinical practice guidelines: vascular Access. 2019. https://www.kidney.org/professionals/guidelines/guidelines_commentaries/vascular-access. Accessed 30 Sep 2020.
4. Schon D, Blume SW, Niebauer K, et al. Increasing the use of arteriovenous fistula in hemodialysis: economic benefits and economic barriers. Clin J Am Soc Nephrol. 2007;2:268–76.
5. Miller PE, Tolwani A, Luscy CP, et al. Predictors of adequacy of arteriovenous fistulas in hemodialysis patients. Kidney Int. 1999;56:275–80.